Oppenheimer & Co’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,950
Closed -$254K 1296
2016
Q4
$254K Sell
2,950
-23,704
-89% -$2.12M 0.01% 1069
2016
Q3
$2.31M Buy
+26,654
New +$2.68M 0.07% 330
2016
Q1
Sell
-11,100
Closed -$988K 1259
2015
Q4
$988K Buy
+11,100
New +$990K 0.03% 556

Other funds holding CRI

Oppenheimer & Co's CRI Position: Q1 2017 in Review

Oppenheimer & Co sold out of Carter's (CRI) in Q1 2017, closing a stake of 2,950 shares — an estimated $254K sold.

Oppenheimer & Co first reported a position in CRI in Q4 2015 and held it in 3 quarters. The position peaked at $2.31M in Q3 2016. 336 funds tracked by Wall St. Rank hold CRI as of Q1 2017.

  • Oppenheimer & Co reported no remaining Carter's position as of Q1 2017 after selling out during the quarter.
  • Oppenheimer & Co sold 2,950 Carter's shares in Q1 2017, an estimated $254K.
  • Oppenheimer & Co first reported a position in Carter's in Q4 2015 and held it in 3 quarters.
  • Oppenheimer & Co's Carter's position peaked at $2.31M in Q3 2016.
  • 336 funds tracked by Wall St. Rank held Carter's as of Q1 2017.

Based on Oppenheimer & Co's 13F filing for Q1 2017, filed 15 May 2017.